European Journal of Pharmacology·14 AugSGLT2 inhibition attenuates cytoskeletal and proteostatic dysfunction through the AGE-RAGE-IGFBP2-FBN1 signaling axis in diabetic lensesExperiments in animalsInterventionsPaper